Keywords: PPP، پلاسمای خون پلاکتی; AMI, acute myocardial infarction; FITC, fluorescein isothiocyanate; GO, graphene oxide; PE, phycoerythrin; PMP, platelet-derived microparticle; PPP, platelet-poor plasma; PRP, platelet-rich plasmaBiosensor; Platelet-derived microparticles; Graphene oxide;
مقالات ISI PPP، پلاسمای خون پلاکتی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Genetic analysis in Factor XI deficient patients from central China: Identification of one novel and seven recurrent mutations
Keywords: PPP، پلاسمای خون پلاکتی; FXI, Factor XI; Ap, apple domains; FXI:C, FXI coagulant activity; FXI:Ag, FXI antigen; PPP, platelet-poor plasma; TGT, thrombin generation test; ETP, endogenous thrombin potential; PDI, protein disulfide isomerase; GM130, Cis-Golgi Marker; ER, endoplasmic
Antiplatelet activity of loureirin A by attenuating Akt phosphorylation: In vitro studies
Keywords: PPP، پلاسمای خون پلاکتی; ADP, adenosine diphosphate; ATP, adenosine triphosphate; CRP, collagen-related peptide; DMSO, dimethyl sulfoxide; EDTA, ethylene diamine tetraacetic acid; PGE1, Prostaglandin E1; PI3K, Phosphoinositide 3-kinase; PPP, platelet-poor plasma; PRP, platelet-ri
Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies
Keywords: PPP، پلاسمای خون پلاکتی; APC, Acquired activated protein C; CAT, Calibrated automated thrombography; ETP, Endogenous thrombin potential; F1+2, Prothrombin fragments 1 + 2; FMC, Fibrin monomer complexes; IQC, Internal quality control; NS, Non significant; PPP, Platelet-poor plasma
Inhibition of platelet aggregation by curdione from Curcuma wenyujin essential Oil
Keywords: PPP، پلاسمای خون پلاکتی; PAF, Platelet-activating factor; ADP, adenosine diphosphate; AA, arachidonic acid; cAMP, cyclic adenosine monophosphate; EGTA, ethylene glycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid; DMSO, dimethyl sulfoxide; PPP, platelet-poor plasma; PRP, pl
Black soybean extract can attenuate thrombosis through inhibition of collagen-induced platelet activation
Keywords: PPP، پلاسمای خون پلاکتی; Anti-CD62P-FITC Ab, FITC-labeled anti-CD62P antibody; anti-GPIb-PE Ab, phycoerythrin-labeled monoclonal antibody against human glycoprotein Ib; BB, black soybean extract; IC50, half maximal inhibitory concentration; PPP, platelet-poor plasma; PRP, platele
The role of protein sulfhydryl groups and protein disulfides of the platelet surface in aggregation processes involving thiol exchange reactions
Keywords: PPP، پلاسمای خون پلاکتی; DTT, dithiothreitol; FITC, fluorescein-isothiocyanate; GSH, glutathione; MPB, N-(3-maleimidylpropionyl)biocytin; NEM, N-ethylmaleimide; PRP, platelet rich plasma; PPP, platelet-poor plasma; PSH, protein SH groups; PSSP, protein disulfides; WP, washed plat
The clock gene Per2 is required for normal platelet formation and function
Keywords: PPP، پلاسمای خون پلاکتی; MK, megakaryocyte; Q-RT-PCR, quantitative reverse transcription PCR; PRP, platelet-rich plasma; PPP, platelet-poor plasma; ADP, adenosine diphosphate; PI, propidium iodide; EDTA, ethylenediaminetetraacetic acid; TEM, transmission electron microscopy; MCHC
Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay
Keywords: PPP، پلاسمای خون پلاکتی; CTI, corn trypsin inhibitor; ETP, endogenous thrombin potential; MP, microparticles; PPL, procoagulant phospholipids; PPP, platelet-poor plasma; TF, tissue factor; TG, thrombin generation; Tlag, lag-time; Ttp, time to peakCancer; Hypercoagulability; Throm
A 2-Step Mechanism of Arterial Thrombus Formation Induced by Human Atherosclerotic Plaques
Keywords: PPP، پلاسمای خون پلاکتی; aggregation; atherothrombosis; collagen; fibrin; glycoprotein VI; plaque; platelet; tissue factor; thrombinCTI, corn trypsin inhibitor; FXII, coagulation factor XII; GPVI, glycoprotein VI; PFP, platelet-free plasma; PPP, platelet-poor plasma; PRP, platele
Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration
Keywords: PPP، پلاسمای خون پلاکتی; AA, arachidonic acid; ADP, adenosine diphoshate; CAD, coronary artery disease; COX-1, cyclooxygenase-1 enzyme; EIA, enzyme immuno assay; NSAIDs, non-steroidal anti-inflammatory drugs; OPA, optical platelet aggregation; PPP, platelet-poor plasma; PRP, plat
Effect of the carthamins yellow from Carthamus tinctorius L. on hemorheological disorders of blood stasis in rats
Keywords: PPP، پلاسمای خون پلاکتی; ADP, adenosine 5′-diphosphate; APTT, activated partial thromboplastin time; ASP, aspirin; CY, carthamins yellow; Fg, fibrinogen; HPLC, high performance liquid chromatography; PPP, platelet-poor plasma; PRP, platelet-rich plasma; PT, prothrombin time; RBC,
Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel
Keywords: PPP، پلاسمای خون پلاکتی; ADP, adenosine diphosphate; CAD, coronary artery disease; CV, coefficient of variation; LTA, light transmission aggregometry; PCI, percutaneous coronary interventions; PPACK, D-phenylalanyl-propyl-arginine chloromethyl ketone; PPP, platelet-poor plasma; P
Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro
Keywords: PPP، پلاسمای خون پلاکتی; ATP, adenosine triphosphate; PRP, platelet-rich plasma; ADP, adenosine dephosphate; PPP, platelet-poor plasma; NO, nitric oxide; eNOS, endothelial nitric oxide synthasePlatelet aggregation; Bortezomib; Proteasome inhibitors
Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens : Results From the PREPAIR Randomized Study
Keywords: PPP، پلاسمای خون پلاکتی; ADP, adenosine diphosphate; Aggpeak, peak aggregation; Agg6min, late aggregation; PCI, percutaneous coronary intervention; PPP, platelet-poor plasma; PRP, platelet-rich plasma
Platelet pro-aggregatory effects of CD40L monoclonal antibody
Keywords: PPP، پلاسمای خون پلاکتی; ASA, acetylsalicylic acid; FcγR, Fc gamma receptors; GP, glycoprotein; PPP, platelet-poor plasma; PRP, platelet-rich plasma; sCD40L, soluble CD40L; TNF, tumor necrosis factor; TXA2, thromboxane A2CD40L immunotherapy; Platelet aggregation; Thrombosis
An ultrastructural study of Porphyromonas gingivalis-induced platelet aggregation
Keywords: PPP، پلاسمای خون پلاکتی; P. gingivalis, Porphyromonas gingivalis; PRP, platelet rich plasma; PPP, platelet-poor plasma; S. aureus, Staphylococcus aureus; OCS, open canalicular system; RR, ruthenium red; HagA, hemagglutinin A; Hgp44, hemagglutinin domain proteins; Rgp, Arg-gingipa
Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents
Keywords: PPP، پلاسمای خون پلاکتی; CA, cinnamaldehyde; AA, arachidonic acid; ADP, adenosine diphosphate; TXA2, thromboxane A2; TXB2, thromboxane B2; ASA, aspirin; PRP, platelet-rich plasma; PPP, platelet-poor plasma; WP, washed plateletsCinnamaldehyde; Hemorrhage time; Coagulation time; Pl
Experimental arterial thrombosis regulated by androgen and its receptor via modulation of platelet activation
Keywords: PPP، پلاسمای خون پلاکتی; ACS, acute coronary syndrome; CAD, coronary artery disease; DHT, 5α-Dihydrotestostosterone; Flut, flutamide; ADP, Adenosine 5′-diphosphate; PRP, platelet-rich plasma; PPP, platelet-poor plasma; TXB2, thromboxane B2; PGI2, prostaglandin I2; 6-Keto-PGF1α, 6
New method to prepare autologous fibrin glue on demand
Keywords: PPP، پلاسمای خون پلاکتی; ELISA, enzyme-linked immunosorbent assay; PEG, polyethylene glycol; PPP, platelet-poor plasma; SD, standard deviation
Calcium ionophore-induced de-encryption of tissue factor in monocytes is associated with extensive cell death
Keywords: PPP، پلاسمای خون پلاکتی; TF, tissue factor; PS, phosphatidylserine; MP, microparticles; LPS, lipopolysaccharide; PPP, platelet-poor plasma; FPA, fibrinopeptide A; F 1 + 2, fragment 1 and 2; TAT, thrombin/antithrombin complex; PBMC, peripheral blood mononuclear cells; FSC, forward
Insulin Therapy Is Associated With Platelet Dysfunction in Patients With Type 2 Diabetes Mellitus on Dual Oral Antiplatelet Treatment
Keywords: PPP، پلاسمای خون پلاکتی; ADP, adenosine diphosphate; CADP, collagen/ADP; CEPI, collagen/epinephrine; CT, closure time; HbA1C, hemoglobin A1C; ITDM, insulin-treated diabetes mellitus; NITDM, noninsulin-treated diabetes mellitus; PPP, platelet-poor plasma; PRP, platelet-rich plasma
Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists
Keywords: PPP، پلاسمای خون پلاکتی; ADP, adenosine 5-diphosphate; CRP, collagen-related peptide; GFP, gel-filtered platelets; GP, glycoprotein; PPACK, d-phenylalanyl-l-prolyl-l-arginine chloromethyl ketone; PPP, platelet-poor plasma; PRP, platelet-rich plasma; GPRP, Gly-Pro-Arg-Pro; TRAP, t
Protein S-glutathionylation and platelet anti-aggregating activity of disulfiram
Keywords: PPP، پلاسمای خون پلاکتی; ALDH, aldehyde dehydrogenase; DTT, dithiothreitol; GSH, reduced glutathione; GSSG, glutathione disulfide; mBrB, monobromobimane; MeDTC-SO, S-methyl-N,N-diethylthiocarbamoyl sulfoxide; NEM, N-ethylmaleimide; PKC, protein kinase C; PPP, platelet-poor plasma
Dependence of Platelet Thrombus Stability on Sustained Glycoprotein IIb/IIIa Activation Through Adenosine 5′-Diphosphate Receptor Stimulation and Cyclic Calcium Signaling
Keywords: PPP، پلاسمای خون پلاکتی; ADP, adenosine diphosphate; [Ca2+]i, intracytoplasmic Ca2+concentration; FITC, fluorescein isothiocyanate; GP, glycoprotein; PPP, platelet-poor plasma; PRP, platelet-rich plasma; VWF, von Willebrand factor